e-learning
resources
Stockholm 2007
Sunday 16.09.2007
Tuberculosis control and HIV in Europe: good or bad news?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The WHO-recommended strategy of tuberculosis control: the new vision of DOTS
M. Uplekar (Geneva, Switzerland)
Source:
Annual Congress 2007 - Tuberculosis control and HIV in Europe: good or bad news?
Session:
Tuberculosis control and HIV in Europe: good or bad news?
Session type:
Symposium
Number:
361
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Uplekar (Geneva, Switzerland). The WHO-recommended strategy of tuberculosis control: the new vision of DOTS. Annual Congress 2007 - Tuberculosis control and HIV in Europe: good or bad news?
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
Results of the implementation of the WHO-recommended TB control strategy in Russia
Source: Eur Respir J 2002; 20: Suppl. 38, 368s
Year: 2002
Effects of DOTS strategy on new confirmed tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 588s
Year: 2006
The effectiveness of the national program tuberculosis control in Ukraine and the future strategy
Source: Eur Respir J 2006; 28: Suppl. 50, 130s
Year: 2006
Tuberculosis-related deaths before and after the implementation of DOTS control program
Source: Annual Congress 2007 - Epidemiological and clinical aspects of tuberculosis control
Year: 2007
New approaches for evaluation of treatment effectiveness among patients with pulmonary TB under DOTS implemented conditions
Source: Eur Respir J 2002; 20: Suppl. 38, 368s
Year: 2002
Cost-effectiveness of adding novel or group 5 interventions to a background regimen for the treatment of multidrug-resistant tuberculosis in Germany
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016
A novel nurse-led approach improves treatment completion rates for latent tuberculosis infection (LTBI) treatment
Source: International Congress 2014 – Mycobacterium tuberculosis infection: new therapeutic approaches
Year: 2014
Evaluation of new smear positive tuberculosis patients 5 years after initiation of treatment under a DOTS programme
Source: Annual Congress 2010 - Tuberculosis epidemiology
Year: 2010
Efficiency of the tuberculosis detection in the implantation of the DOTS program
Source: Eur Respir J 2007; 30: Suppl. 51, 422s
Year: 2007
Old ideas to innovate tuberculosis control: preventive treatment to achieve elimination
Source: Eur Respir J 2013; 42: 785-801
Year: 2013
TB "cross-border" - a new challenge in tuberculosis management
Source: Virtual Congress 2020 – Tuberculosis and society
Year: 2020
Drug resistance in previously treated patients of tuberculosis in pre DOTS and DOTS era and its implications
Source: Annual Congress 2009 - Tuberculosis control
Year: 2009
Gene-Xpert for rapid detection of MDR-TB in re-treatment cases;a comparison with standard culture and DST
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015
MDR-TB guidelines: what is new on clinical management
Source: ERS Webinar 2020: MDR-TB guidelines: what is new on clinical management
Year: 2020
MDR-TB management: what is new?
Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination
Year: 2012
Results of the treatment of relapses of tuberculosis by DOTS method
Source: Eur Respir J 2001; 18: Suppl. 33, 339s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept